Investment Summary

Symrise Invests In Bonumose

On July 13, 2023, Symrise invested in food company Bonumose

Investment Highlights
  • This is Symrise’s 5th transaction in the Food sector.
  • This is Symrise’s 8th transaction in the United States.
  • This is Symrise’s 1st transaction in Virginia.

Investment Summary

Date 2023-07-13
Target Bonumose
Sector Food
Investor(s) Symrise
Deal Type Growth Capital

Target

Bonumose

Charlottesville, Virginia, United States
Bonumose is a food ingredient manufacturer that specializes in the affordable production of delicious, good-for-you rare monosaccharides (alternatives to sucrose) such as tagatose and allulose. Bonumose was formed in 2016 and is based in Charlottesville, Virginia.

Search 214,107 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Investor(S) 1

Investor

Symrise

Holzminden, Germany

Category Company
Founded 1874
Sector Chemicals
Employees12,984
Revenue 5.0B EUR (2024)
DESCRIPTION

Symrise is a producer of flavours, fragrances, cosmetic ingredients and aroma chemicals in the world. Symrise was founded in 1874 and is based in Holzminden, Germany.


DEAL STATS #
Overall 14 of 15
Sector: Food M&A 5 of 5
Type: Growth Capital M&A Deals 1 of 2
State: Virginia M&A 1 of 1
Country: United States M&A 8 of 9
Year: 2023 M&A 2 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2023-01-23 EvodiaBio

Copenhagen, Denmark

EvodiaBio is a commercial company in rooted in research to reinventing the production of natural aromas for a more sustainable world. It has developed a ground-breaking technology platform that uses precision fermentation to produce sustainable taste for the food and beverage industry, with the potential to go beyond this market. EvodiaBio was formed in 2021 and is based in Copenhagen, Denmark.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2025-10-22 Cellibre

San Diego, California, United States

Cellibre develops biomanufacturing technology that uses cellular engineering and precision fermentation to produce sustainable, high-value ingredients. The Company applies strain design, protein optimization, and fermentation processes to create bio-based alternatives for industries such as nutrition, pharmaceuticals, and specialty chemicals. Cellibre was founded in 2018 and is headquartered in San Diego, California.

Buy -